Cubact 500 mg POWDER FOR SOLUTION FOR INFUSION
PDF Leaflet Revision Date: May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Indicated for complicated skin infections and Staphylococcus aureus bloodstream infections.
Dosage (summary)
cSSSI: 4 mg/kg IV once daily; SAB: 6 mg/kg IV once daily.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Increased risk of myopathy with statins
- Warfarin monitoring required
Contraindications
- Hypersensitivity to daptomycin
- Treatment of pneumonia
Common side effects
- Dizziness
- Nausea
- Rash
- Increased CPK
Counselling Points
- Monitor for muscle pain or weakness
- Avoid driving if dizzy
- Report any allergic reactions
Serious warnings
- Risk of myopathy
- Not effective for pneumonia
- Anaphylaxis possible
Important Disclaimer
The Cubact 500 mg POWDER FOR SOLUTION FOR INFUSION professional information leaflet below is the property of Abex Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
